AU StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Novel Coronavirus Treatment

1,051.051

-13.917-1.31%

Number of Gainers:12

Number of Losers:4

Number of Flat:16

PE:- -

High:1,066.940

Open:1,066.713

Low:1,050.357

Close:1,064.969

Loading ...

Dimerix Ltd - Dimerix and Amicus Therapeutics Announce Exclusive License Agreement for Dmx-200 in United States

THOMSON REUTERS

Dimerix Ltd - Dimerix to Receive US$30 Mln Upfront Payment

THOMSON REUTERS

Woolworths - Weather Events Have Led to Additional Costs of a$20-25 Mln Due to Higher Stockloss

THOMSON REUTERS

Woolworths - Market Remains Competitive and Consumer Outlook Uncertain

THOMSON REUTERS

Woolworths - Qtrly Australian Food Sales a$13,051 Mln

THOMSON REUTERS

Investors in Healius (ASX:HLS) have unfortunately lost 63% over the last three years

Simply Wall St.

Australia's CSL evaluates China tariff exemptions for its US-made drugs

Mesoblast Plans to Double Transplant Centers Onboarded for Graft Versus Host Disease Treatment

MT Newswires Live

These ASX 200 shares could rise 30% to 40%

The ultimate blue chip portfolio: 3 ASX 200 stocks to anchor your investments

Aussie shares pare gains after local inflation data tops forecast

The five numbers that explain why Coles is beating Woolies

The Australian Financial Review

CSL Unit, US Partner Say European Commission Grants Marketing Authorization for Kidney Disease Treatment Drug

MT Newswires Live

Press Release: Appendix 4c Quarterly Activity Report for Quarter Ended March 31, 2025

CSL Unit Awarded Contract by EU Regulator to Reserve 27 Million Flu Vaccine Doses

MT Newswires Live

This is the number one factor I look for when buying ASX dividend shares

Zoono Group Ltd - Improved Sales Revenues Expected in Q4 FY25 and Q1 FY26

THOMSON REUTERS

Coles - Qtrly Total Group Sales Revenue a$10,379 Mln

THOMSON REUTERS

Coles Group Ltd - in Early Part of Q4, Supermarkets Sales Growth Has Remained Broadly in Line With Q3

THOMSON REUTERS

How to turn $100 a week into $500,000 with ASX shares

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BK7501/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK7501","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK7501\",,,,,undefined,":{"symbol":"BK7501","market":"AU","secType":"PLATE","nameCN":"Novel Coronavirus Treatment","latestPrice":1051.0513,"timestamp":1746597599724,"preClose":1064.9688,"halted":0,"volume":29590091,"delay":0,"changeRate":-0.013068,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Closed","change":-13.91748,"latestTime":"05-07 16:00:00 AEST","open":1066.7125,"high":1066.94,"low":1050.3573,"amount":326803591,"amplitude":0.015571,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1746662400000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1746576000000,1746597600000]],"turnoverRate":0.002092,"increases":9,"decrements":6,"flats":18,"marketCap":270221168652.75,"floatMarketCap":219008551935.21094},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK7501\",,,,,undefined,":{"symbol":"BK7501","high":1066.94,"amplitude":0.015571,"preClose":1064.9688,"low":1050.3573,"latestPrice":1051.0513,"volume":29590091,"delay":0,"open":1066.7125,"prevYearClose":1117.913,"prevWeekClose":1079.952,"prevMonthClose":1052.524,"prevQuarterClose":1021.93,"fiveDayClose":1052.524,"twentyDayClose":1056.142,"sixtyDayClose":1076.83,"secType":"PLATE","market":"AU","turnoverRate":0.002092,"marketCap":270221168652.75,"floatMarketCap":219008551935.21094,"timestamp":1746597599724,"nameCN":"Novel Coronavirus Treatment"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK7501\",,,,undefined,":{"bkCode":"BK7501","up":12,"down":4,"flat":16},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK7501\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2532130930","title":"Dimerix Ltd -  Dimerix and Amicus Therapeutics Announce Exclusive License Agreement for Dmx-200 in United States","url":"https://stock-news.laohu8.com/highlight/detail?id=2532130930","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532130930?lang=en_us&edition=fundamental","pubTime":"2025-05-01 07:10","pubTimestamp":1746054655,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250430:nFWN3R8371:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7501","DXB.AU","BK7067","BK7508"],"gpt_icon":0},{"id":"2532015821","title":"Dimerix Ltd -  Dimerix to Receive US$30 Mln Upfront Payment","url":"https://stock-news.laohu8.com/highlight/detail?id=2532015821","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532015821?lang=en_us&edition=fundamental","pubTime":"2025-05-01 07:10","pubTimestamp":1746054655,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250430:nFWN3R8371:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","BK7501","BK7067","DXB.AU"],"gpt_icon":0},{"id":"2532201090","title":"Woolworths - Weather Events Have Led to Additional Costs of a$20-25 Mln Due to Higher Stockloss","url":"https://stock-news.laohu8.com/highlight/detail?id=2532201090","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532201090?lang=en_us&edition=fundamental","pubTime":"2025-05-01 06:36","pubTimestamp":1746052564,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250430:nPLX019EA3:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7040","BK7511","BK7501","WOW.AU"],"gpt_icon":0},{"id":"2532209027","title":"Woolworths - Market Remains Competitive and Consumer Outlook Uncertain","url":"https://stock-news.laohu8.com/highlight/detail?id=2532209027","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532209027?lang=en_us&edition=fundamental","pubTime":"2025-05-01 06:35","pubTimestamp":1746052534,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250430:nFWN3R836Y:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["WOW.AU","BK7511","BK7040","BK7501"],"gpt_icon":0},{"id":"2532090277","title":"Woolworths - Qtrly Australian Food Sales a$13,051 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2532090277","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532090277?lang=en_us&edition=fundamental","pubTime":"2025-05-01 06:35","pubTimestamp":1746052534,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250430:nFWN3R836Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7511","WOW.AU","BK7040","BK7501"],"gpt_icon":0},{"id":"2532018545","title":"Investors in Healius (ASX:HLS) have unfortunately lost 63% over the last three years","url":"https://stock-news.laohu8.com/highlight/detail?id=2532018545","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532018545?lang=en_us&edition=fundamental","pubTime":"2025-05-01 06:11","pubTimestamp":1746051079,"startTime":"0","endTime":"0","summary":"If you are building a properly diversified stock portfolio, the chances are some of your picks will perform badly. But long term Healius Limited  shareholders have had a particularly rough ride in the last three year. Regrettably, they have had to cope with a 67% drop in the share price over that period. On the other hand the share price has bounced 6.6% over the last week. The buoyant market could have helped drive the share price pop, since stocks are up 3.3% in the same period.Now let's have a look at the company's fundamentals, and see if the long term shareholder return has matched the performance of the underlying business.We're pleased to report that Healius shareholders have received a total shareholder return of 27% over one year. There's no doubt those recent returns are much better than the TSR loss of 6% per year over five years. This makes us a little wary, but the business might have turned around its fortunes. I find it very interesting to look at share price over the lo","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/investors-healius-asx-hls-unfortunately-221119809.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["BK7501","BK7509","HLS.AU","ISBC","BK4211","BK7124"],"gpt_icon":0},{"id":"2531876730","title":"Australia's CSL evaluates China tariff exemptions for its US-made drugs","url":"https://stock-news.laohu8.com/highlight/detail?id=2531876730","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531876730?lang=en_us&edition=fundamental","pubTime":"2025-04-30 18:17","pubTimestamp":1746008273,"startTime":"0","endTime":"0","summary":"SHANGHAI  -Australia's CSL Ltd said it's evaluating whether its drugs used in surgery would be exempted from 125% tariffs China imposed on U.S.-made goods, as it seeks to minimise impact of a trade war between Beijing and Washington.China has granted tariff exemptions on select products, including select pharmaceuticals, and has also created a non-public list of goods that would be exempted from duties, Reuters reported earlier on Wednesday, in the clearest sign yet of Beijing's concerns about the trade war's fallout.The quiet approach allows Beijing, which has repeatedly said it is willing to fight until the end unless the U.S. lifts its 145% tariffs on Chinese imports, to maintain its public messaging while privately taking practical steps to provide concessions.\"We are aware of reports that certain goods imported from the U.S. into China are potentially being exempted from tariffs,\" a spokesperson for CSL told Reuters in a statement.\"We are working to determine the potential for our","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/australias-csl-evaluates-china-tariff-101753571.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["SGXZ23171101.USD","LU1169590202.USD","LU1169589451.USD","XAO.AU","XKO.AU","BK7501","BK7511","CSL.AU","BK7067","LU0728928796.USD","BK4086","CSL","BK7508","XJO.AU","SG9999004303.SGD"],"gpt_icon":0},{"id":"2531771066","title":"Mesoblast Plans to Double Transplant Centers Onboarded for Graft Versus Host Disease Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2531771066","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531771066?lang=en_us&edition=fundamental","pubTime":"2025-04-30 14:17","pubTimestamp":1745993866,"startTime":"0","endTime":"0","summary":"Mesoblast  onboarded ten transplant centers in the US for the supply of Ryoncil for the treatment of steroid-refractory acute graft versus host disease during the March quarter, and the firm plans to recruit ten more priority transplant centers during the June quarter, according to a Wednesday Australian bourse filing.The firm brought on board a team of nine key account managers in the last week of April, who will focus on onboarding the remaining 35 priority transplant centers, accounting for 80% of US pediatric transplants.It also secured a Type B meeting with the US Food and Drug Administration scheduled for the June quarter to discuss the accelerated approval pathway for Revascor, a candidate for the treatment of patients with ischemic chronic heart failure with reduced ejection fraction and inflammation.Its shares fell 2% in recent trading on Wednesday.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4218","BK4585","BK4139","BK7508","BK7501","MESO","HST","MSB.AU","BK4588","BK7067","BK4181"],"gpt_icon":0},{"id":"2531770438","title":"These ASX 200 shares could rise 30% to 40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2531770438","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531770438?lang=en_us&edition=fundamental","pubTime":"2025-04-30 13:30","pubTimestamp":1745991034,"startTime":"0","endTime":"0","summary":"If you are on the hunt for big returns for your investment portfolio, then keep reading. That's because listed below are two ASX 200 shares that have been named as buys and tipped to rise over 30% fro","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/04/30/these-asx-200-shares-could-rise-30-to-40-2/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK7095","BK7007","BK7507","BK7501","RMD.AU","BK7504","MIN.AU"],"gpt_icon":0},{"id":"2531872719","title":"The ultimate blue chip portfolio: 3 ASX 200 stocks to anchor your investments","url":"https://stock-news.laohu8.com/highlight/detail?id=2531872719","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531872719?lang=en_us&edition=fundamental","pubTime":"2025-04-30 11:46","pubTimestamp":1745984811,"startTime":"0","endTime":"0","summary":"If you're building a long-term investment portfolio, it can pay to start with the best. ASX 200 blue chip stocks — the large, established companies with strong track records and durable earnings — off","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/04/30/the-ultimate-blue-chip-portfolio-3-asx-200-stocks-to-anchor-your-investments/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["LU2237443465.HKD","LU1868837300.USD","IE00BFXG1179.USD","LU2750360641.GBP","WOW.AU","LU0251142724.SGD","REA.AU","BK4127","LU2750360997.AUD","LU0742534661.SGD","LU0096364046.USD","LU2471134796.USD","BK7511","IE0034235188.USD","IE00B19Z3581.USD","XAO.AU","BK7002","IE0002270589.USD","BK4588","LU2237443622.USD","LU2471134952.CNY","BK7067","LU0106831901.USD","LU2237438978.USD","LU1868836591.USD","XJO.AU","LU0048573561.USD","LU0251131958.USD","BK4533","LU1791807156.HKD","LU2237443382.USD","BK4516","XKO.AU","LU0061475181.USD","CSL.AU","IE00B19Z3B42.SGD","LU2471134879.HKD","LU1868836757.USD","LU1868836914.USD","LU2237443978.SGD","BK4504","BK4550","LU2471134523.USD","LU1868837136.USD","LU2237443895.HKD","BK7040","IE0004091025.USD","IE00BSNM7G36.USD","BK7501","BK4585"],"gpt_icon":0},{"id":"2531723854","title":"Aussie shares pare gains after local inflation data tops forecast","url":"https://stock-news.laohu8.com/highlight/detail?id=2531723854","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531723854?lang=en_us&edition=fundamental","pubTime":"2025-04-30 10:26","pubTimestamp":1745979974,"startTime":"0","endTime":"0","summary":"Aussie shares pare gains after local inflation data tops forecastUpdates with inflation data, share moves","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250430:nL4N3R806C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7006","BK7130","BK7507","ORG.AU","BK7040","BK7082","COL.AU","BK7501"],"gpt_icon":0},{"id":"2531252767","title":"The five numbers that explain why Coles is beating Woolies","url":"https://stock-news.laohu8.com/highlight/detail?id=2531252767","media":"The Australian Financial Review","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531252767?lang=en_us&edition=fundamental","pubTime":"2025-04-30 10:00","pubTimestamp":1745978400,"startTime":"0","endTime":"0","summary":"You only need to look at Coles’ and Woolworths’ share prices to see how the gap between Australia’s supermarket powerhouses has opened up in the past 12 months: Woolworths’ stock has gone nowhere despite its obvious defensive qualities, while Coles is up more than 31 per cent.Five numbers contained in the March quarter sales chief executive Leah Weckert delivered on Wednesday help explain this divergence. For the moment at least, Team Down Down appears to be showing the Fresh Food People a clean pair of heels.Loading...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.afr.com/chanticleer/the-five-numbers-that-explain-why-coles-is-beating-woolies-20250430-p5lvc5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"afr_stock","symbols":["COL.AU","BK7082","WOW.AU","BK7501","BK7511","BK7040"],"gpt_icon":1},{"id":"2531774643","title":"CSL Unit, US Partner Say European Commission Grants Marketing Authorization for Kidney Disease Treatment Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2531774643","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531774643?lang=en_us&edition=fundamental","pubTime":"2025-04-30 08:57","pubTimestamp":1745974653,"startTime":"0","endTime":"0","summary":"CSL's  Switzerland-based pharmaceutical unit, CSL Vifor, and US biopharmaceutical firm Travere Therapeutics said the European Commission has granted standard marketing authorization for Filspari, a treatment for primary IgA nephropathy , a rare and progressive kidney disease, according to a Tuesday statement by the company.The decision converts a previous conditional marketing authorization and extends to all European Union member states, as well as Iceland, Liechtenstein, and Norway, the company said.Filspari was developed by Travere Therapeutics and exclusively licensed to CSL Vifor for commercialization in Europe, Australia, and New Zealand.CSL's shares rose 1% in recent Wednesday trade.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CSL","CSL.AU","BK7501","BK7067","BK7508","LU0728928796.USD","SG9999004303.SGD","LU1169590202.USD","SGXZ23171101.USD","BK7511","BK4086","LU1169589451.USD"],"gpt_icon":0},{"id":"2531746982","title":"Press Release: Appendix 4c Quarterly Activity Report for Quarter Ended March 31, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2531746982","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531746982?lang=en_us&edition=fundamental","pubTime":"2025-04-30 08:53","pubTimestamp":1745974380,"startTime":"0","endTime":"0","summary":"NEW YORK, April 29, 2025  -- Mesoblast Limited , global leader in allogeneic cellular medicines for inflammatory diseases, today provided highlights of its recent activities for the third quarter ended March 31, 2025.\"We were very pleased to have made Ryoncil  commercially available to treat children with acute GVHD within one quarter of receiving FDA approval as the first mesenchymal stromal cell  therapy approved in the US for any indication,\" said Dr. Silviu Itescu, CEO of Mesoblast. \"With our strong cash position we are well placed to expand Ryoncil indications to other serious and life-threatening pediatric inflammatory diseases, and to adults with acute GvHD.\". -- Net operating cash spend for the quarter was US$12.7 million.-- Cash on hand at the end of the quarter was US$182 million (A$290. -- Ryoncil became commercially available for purchase in the United. States on March 28, 2025, with Federal Medicaid coverage, and to date 15. infusion kits have been purchased for patients t","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B1BXHZ80.USD","BK4585","03160","BK4232","MESO","CMC","BK4588","LU0149725797.USD","BK4170","BK4022","IE00BKVL7J92.USD","BK4139","BK4161","BK4546","BK4150","BK4555","BK7067","BK4526","BK4604","BK4099","MSB.AU","BK4141","BK4006","BK4575","LU0267386448.USD","BK7508","MSC","IE00BZ1G4Q59.USD","LU0971096721.USD","MSB","R","BK4543","BK4551","DDD","ASX","LU0882574139.USD","IE00BHPRN162.USD","LU0170899867.USD","BK7501","LU1363072403.SGD","TM"],"gpt_icon":0},{"id":"2531774308","title":"CSL Unit Awarded Contract by EU Regulator to Reserve 27 Million Flu Vaccine Doses","url":"https://stock-news.laohu8.com/highlight/detail?id=2531774308","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531774308?lang=en_us&edition=fundamental","pubTime":"2025-04-30 08:31","pubTimestamp":1745973088,"startTime":"0","endTime":"0","summary":"CSL  said Tuesday CSL Seqirus was awarded a contract by the Health Emergency Preparedness and Response Authority to support the pandemic preparedness plans of 17 European Union and European Economic Area member states as well as the European Commission.Under the contract, 27 million doses of pandemic influenza vaccine have been reserved with CSL Seqirus, which can be ordered by the participating countries in the event of an influenza pandemic, according to a statement.The deal requires CSL Seqirus to be prepared to rapidly manufacture and deliver these vaccine doses. The doses will be produced at the company's manufacturing site in Liverpool, UK.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7067","CSL","CSL.AU","LU0728928796.USD","BK4086","SG9999004303.SGD","LU1169589451.USD","LU1169590202.USD","BK7511","BK7501","SGXZ23171101.USD","BK7508","BK4156"],"gpt_icon":0},{"id":"2531108157","title":"This is the number one factor I look for when buying ASX dividend shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2531108157","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531108157?lang=en_us&edition=fundamental","pubTime":"2025-04-30 07:30","pubTimestamp":1745969400,"startTime":"0","endTime":"0","summary":"ASX dividend shares can be great investments. However, there's a particular factor that I look for the most when it comes to passive income.  When it comes to businesses that paydividends, there are various elements to consider. How big is the dividend yield?","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/04/30/this-is-the-number-one-factor-i-look-for-when-buying-asx-dividend-shares/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK7094","BKW.AU","BK7040","BK7129","WTC.AU","ANZ.AU","BHP.AU","BK7105","BK7501","WBC.AU","BK7503","BK7124","BK7095","BK7083","TNE.AU","NAB.AU","BK7044","FMG.AU","BK7016","BK7082","RIO.AU","SHL.AU","COL.AU","BK7507","BK7511","SOL.AU","PME.AU","BK7135"],"gpt_icon":0},{"id":"2531915712","title":"Zoono Group Ltd - Improved Sales Revenues Expected in Q4 FY25 and Q1 FY26","url":"https://stock-news.laohu8.com/highlight/detail?id=2531915712","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531915712?lang=en_us&edition=fundamental","pubTime":"2025-04-30 07:17","pubTimestamp":1745968638,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250429:nFWN3R725D:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ZNO.AU","BK7036","BK7501"],"gpt_icon":0},{"id":"2531711364","title":"Coles - Qtrly Total Group Sales Revenue a$10,379 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2531711364","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531711364?lang=en_us&edition=fundamental","pubTime":"2025-04-30 06:43","pubTimestamp":1745966590,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250429:nPLX09113F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7501","BK7082","COL.AU","BK7040"],"gpt_icon":0},{"id":"2531384711","title":"Coles Group Ltd - in Early Part of Q4, Supermarkets Sales Growth Has Remained Broadly in Line With Q3","url":"https://stock-news.laohu8.com/highlight/detail?id=2531384711","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531384711?lang=en_us&edition=fundamental","pubTime":"2025-04-30 06:42","pubTimestamp":1745966553,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250429:nFWN3R727L:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7501","BK7082","COL.AU","BK7040"],"gpt_icon":0},{"id":"2531071038","title":"How to turn $100 a week into $500,000 with ASX shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2531071038","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531071038?lang=en_us&edition=fundamental","pubTime":"2025-04-30 06:15","pubTimestamp":1745964914,"startTime":"0","endTime":"0","summary":"Investing can seem daunting at first — especially if you're starting small. But here's the good news: you don't need a huge salary, a stock-picking superpower, or perfect timing to build serious wealt","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/04/30/how-to-turn-100-a-week-into-500000-with-asx-shares/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["WTC.AU","IVV.AU","VGS.AU","BK7016","BK7007","BK7508","BK7503","WES.AU","BK7067","BK7041","BK7501","BK7153","CSL.AU","BK7511","RMD.AU"],"gpt_icon":0}],"pageSize":20,"totalPage":7,"pageCount":4,"totalSize":129,"code":"91000000","status":"200"}]}}